Takeda Pharmaceutical Co earnings were -$1.0B for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest TAK earnings report on Jun 30, 2026 announced Q2 2026 earnings of $700.8M, down 130.4% from last quarter. For the last reported fiscal year 2026 ending Mar 31, 2026, TAK reported annual earnings of -$954.2M, with -232% growth. The next TAK earnings date is Oct 29, 2026.
Takeda Pharmaceutical Co Earnings Reports & History FAQ
What were Takeda Pharmaceutical Co's earnings last quarter?
On TAK's earnings call on Jul 30, 2026, Takeda Pharmaceutical Co (NYSE: TAK) reported Q2 2026 earnings per share (EPS) of $0.22, up 18.98% year over year. Total TAK earnings for the quarter were $700.84 million. In the same quarter last year, Takeda Pharmaceutical Co's earnings per share (EPS) was $0.27.
When does Takeda Pharmaceutical Co report earnings?
The next TAK earnings date is Oct 29, 2026. Add TAK to your watchlist to be reminded of Takeda Pharmaceutical Co's next earnings date.
What was TAK's earnings growth in the past year?
As of Takeda Pharmaceutical Co's earnings date in Jul 30, 2026, Takeda Pharmaceutical Co's earnings has grown year over year. TAK earnings in the past year totalled -$1.01 billion.
Is Takeda Pharmaceutical Co profitable or losing money?
As of the last Takeda Pharmaceutical Co earnings report, Takeda Pharmaceutical Co is currently losing money. Takeda Pharmaceutical Co's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$1.01 billion, a 206.95% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.